Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

DBV Submits VIASKIN Peanut Patch for FDA Approval Following Phase 3 Success

Aquestive Resubmits Needle-Free Sublingual Epinephrine to FDA for Approval

Potential Breakthrough for Celiac Disease: Teva Antibody Significantly Reduces Gluten-Induced Gut Damage

Rare Antibodies Could Lead to First Targeted Treatment for Alpha-Gal Syndrome

Another Potential Food Allergy Treatment is Snapped Up by Big Pharma

Alladapt’s Multi-Allergen OIT Candidate Shows Promise in Clinical Study

Study: Specialized Toothpaste May Lower Risk of Reactions in Adults with...

Study Explores Oral Immunotherapy to Treat Babies with Peanut Allergies

New Cancer Drug Shows Promise for Treating Food Allergies

Needle-Free Powder Epinephrine Nasal Spray Shows Positive Results in Clinical Study

Microneedle Patch to Treat Peanut Allergy Receives Clinical Trial Grant

FDA Delays Approval of neffy™ Intranasal Epinephrine Until September

Viatris, Seller of EpiPen®, Petitions FDA to Delay Approval of neffy™...

Alladapt Announces Positive Results for Multi-Allergen OIT Candidate from Phase 1/2...

FDA Panel Supports Approval of neffy® Epinephrine Nasal Spray

Follow Us

Your School On Our Map

Put Your School on the Map